Company intelligence / Profile preview

Dibo Pharmaceuticals

Quzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Dibo Pharmaceuticals is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses on a broad range of therapeutic areas, including anti-infectives, cardiovascular health, and anti-inflammatory treatments. Dibo operates high-standard manufacturing facilities that comply with international GMP requirements, serving both domestic and global markets. In addition to its own product portfolio, the company provides contract manufacturing and custom synthesis services to international partners.

Therapeutic areas: CardiovascularImmunologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Dibo Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dibo Pharmaceuticals.

Explore the full profile